Technical Analysis for SGHT - Sight Sciences, Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Doji - Bearish? | Reversal | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | 6.65% | |
| Narrow Range Bar | Range Contraction | 6.65% | |
| Inside Day | Range Contraction | 6.65% | |
| Wide Bands | Range Expansion | 6.65% | |
| Oversold Stochastic | Weakness | 6.65% | |
| Doji - Bullish? | Reversal | 7.51% |
| Alert | Time |
|---|---|
| 10 DMA Support | 1 day ago |
| 2x Volume Pace | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
| Up 10% | 1 day ago |
| Gapped Up (Full) | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Sight Sciences, Inc., an ophthalmic medical device company, engages the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology, for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Sector: Healthcare
Industry: Medical Devices
Keywords: Ophthalmology Glaucoma Eye Diseases Vision Dry Eye Disease Optometry Therapeutic Device Eye Care Professional Intraocular Pressure Treatment Of Dry Eye Disease Treatment Of Eye Diseases
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Ophthalmology Glaucoma Eye Diseases Vision Dry Eye Disease Optometry Therapeutic Device Eye Care Professional Intraocular Pressure Treatment Of Dry Eye Disease Treatment Of Eye Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.45 |
| 52 Week Low | 2.58 |
| Average Volume | 201,520 |
| 200-Day Moving Average | 5.78 |
| 50-Day Moving Average | 5.42 |
| 20-Day Moving Average | 4.45 |
| 10-Day Moving Average | 3.95 |
| Average True Range | 0.31 |
| RSI (14) | 37.50 |
| ADX | 37.08 |
| +DI | 17.70 |
| -DI | 29.81 |
| Chandelier Exit (Long, 3 ATRs) | 4.60 |
| Chandelier Exit (Short, 3 ATRs) | 4.57 |
| Upper Bollinger Bands | 5.63 |
| Lower Bollinger Band | 3.27 |
| Percent B (%b) | 0.31 |
| BandWidth | 53.14 |
| MACD Line | -0.49 |
| MACD Signal Line | -0.48 |
| MACD Histogram | -0.01 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.33 | ||||
| Resistance 3 (R3) | 4.34 | 4.24 | 4.27 | ||
| Resistance 2 (R2) | 4.24 | 4.16 | 4.24 | 4.25 | |
| Resistance 1 (R1) | 4.13 | 4.11 | 4.08 | 4.12 | 4.24 |
| Pivot Point | 4.03 | 4.03 | 4.01 | 4.03 | 4.03 |
| Support 1 (S1) | 3.92 | 3.95 | 3.87 | 3.91 | 3.78 |
| Support 2 (S2) | 3.82 | 3.90 | 3.82 | 3.77 | |
| Support 3 (S3) | 3.71 | 3.82 | 3.75 | ||
| Support 4 (S4) | 3.70 |
